Bio Green Med Solution, Inc. — Director's Dealing 2010

Apr 27, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2010-04-23

Reporting Person: Rombotis Spiro George (Director, President & C.E.O.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-04-23	Common Stock, $0.001 par value per share	S	8350	$2.50	Disposed	483198	Direct

Footnotes

F1: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Rombotis.

F2: Of the shares of common stock reported, 1,000 shares are held indirectly by Mr. Rombotis through his IRA account and 32,290 shares are represented by unvested restricted stock units.